Company Filing History:
Years Active: 2019
Title: Liron Abrahami: Innovator in Androgen-Dependent Disorder Treatments
Introduction
Liron Abrahami is a notable inventor based in Kibbutz Maagan Michael, Israel. He has made significant contributions to the field of medical treatments, particularly focusing on androgen-dependent disorders. His innovative approach combines biotechnology with therapeutic applications, showcasing his expertise and dedication to improving health outcomes.
Latest Patents
Liron Abrahami holds a patent for a composition and method for treating androgen-dependent disorders. This patent, titled "Composition and method for treating androgen-dependent disorders," involves chimeric polypeptides that include a dihydrotestosterone (DHT) reductase moiety, such as 3 alpha-hydroxysteroid dehydrogenase (3α-HSD), fused to a signal peptide moiety. The invention also encompasses polynucleotides encoding these components and compositions that include at least one microorganism cell capable of secreting the chimeric polypeptide. The methods and kits provided by this patent aim to treat, prevent, or ameliorate androgen-dependent disorders, including androgenic alopecia. Liron Abrahami has 1 patent to his name.
Career Highlights
Liron Abrahami is associated with the Technion Research & Development Foundation Limited, where he continues to advance his research and innovations. His work is characterized by a strong emphasis on practical applications of scientific discoveries, particularly in the realm of health and medicine.
Collaborations
Liron collaborates with talented individuals such as Roee Amit and Alexey Tomsov, contributing to a dynamic research environment that fosters innovation and creativity.
Conclusion
Liron Abrahami's contributions to the treatment of androgen-dependent disorders highlight his role as a forward-thinking inventor in the medical field. His innovative patent and collaborative efforts reflect a commitment to enhancing therapeutic options for patients.